Product screening
Antibodies
Proteins
CYP2C8/9/18/19 Polyclonal Antibody
{pboot:if('CYP2C8;Cytochrome P450 2C8;CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;CYP2C9;CYP2C10;Cytochrome P450 2C9;R;-limonene 6-monooxygenase;S;-limonene'!='')}Alias:CYP2C8;Cytochrome P450 2C8;CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;CYP2C9;CYP2C10;Cytochrome P450 2C9;R;-limonene 6-monooxygenase;S;-limonene{/pboot:if}
CatalogNo:HJRLT1213
Specifications
50μL;100μL
Delivery date
Spot
Target
CYP2C8/9/18/19
Reactivity
Human
Application - After Update
WB,IHC,IF,ELISA
MW(Observed)
60kD
Host Species
Rabbit
Isotype
IgG
Modify
Unmodified
Recommended dilution ratio
WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:20000;Not yet tested in other applications.
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human Cytochrome P450 2C8/9/18/19. AA range:111-160
Specificity
CYP2C8/9/18/19 Polyclonal Antibody detects endogenous levels of CYP2C8/9/18/19 protein.
Gene name
CYP2C8/9/18/19
Protein name
Cytochrome P450 2C8/9/18/19
Organism-1
Human